Inc. stock despite strong Phase 2b data. Click for my updated look at MNMD stock and its market opportunities.

Cigna Group plans to limit patients’ out-of-pocket expenses for medications as the insurer faces pressure from Washington ...

Akero Therapeutics (AKRO) stock soared 115% after the company reported positive long-term results from a Phase 2b study of ...

The new treatment targets gut hormone GLP-1 but also mimics amylin, a hormone released by the pancreas that suppresses hunger ...

Texas Instruments falls after the chip maker’s first-quarter earnings forecast misses estimates, and Boeing declines after ...

KEY TAKEAWAYS Novo Nordisk's U.S.-listed shares are surging 9% Friday morning after the Danish drugmaker reported early stage ...

That's why the stock, trading just under 9 times forward earnings estimates right now, looks like a great bargain that value ...

Decided to add this retail giant to your portfolio? Here's what you need to know before buying Amazon stock. Many, or all, of the products featured on this page are from our advertising partners ...

Walgreens shares sank Tuesday, the first day of trading since the Department of Justice announced a lawsuit accusing the ...

Neumora Therapeutics Inc.’s stock tumbled 81% Thursday after the clinical-stage biotech said a late-stage trial of a treatment for major depressive disorder failed to meet its main goals.